Pillay D - Search Results

1

HIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy.

Kemp SA, Charles OJ, Derache A, Smidt W, Martin DP, Iwuji C, Adamson J, Govender K, de Oliveira T, Dabis F, Pillay D, Goldstein RA, Gupta RK. Kemp SA, et al. Among authors: pillay d. mBio. 2022 Jun 28;13(3):e0026922. doi: 10.1128/mbio.00269-22. Epub 2022 Apr 21. mBio. 2022. PMID: 35446121 Free PMC article.

2

HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy.

Hué S, Clewley JP, Cane PA, Pillay D. Hué S, et al. Among authors: pillay d. AIDS. 2004 Mar 26;18(5):719-28. doi: 10.1097/00002030-200403260-00002. AIDS. 2004. PMID: 15075506

3

Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom.

Pillay D, Green H, Matthias R, Dunn D, Phillips A, Sabin C, Evans B; UK Collaborative Group on HIV Drug Resistance. Pillay D, et al. J Infect Dis. 2005 Sep 15;192(6):967-73. doi: 10.1086/432763. Epub 2005 Aug 12. J Infect Dis. 2005. PMID: 16107948

4

The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy.

Pillay D, Bhaskaran K, Jurriaans S, Prins M, Masquelier B, Dabis F, Gifford R, Nielsen C, Pedersen C, Balotta C, Rezza G, Ortiz M, de Mendoza C, Kücherer C, Poggensee G, Gill J, Porter K; CASCADE Virology Collaboration. Pillay D, et al. AIDS. 2006 Jan 2;20(1):21-8. doi: 10.1097/01.aids.0000196172.35056.b7. AIDS. 2006. PMID: 16327315

5

Evolution of transmitted HIV-1 with drug-resistance mutations in the absence of therapy: effects on CD4+ T-cell count and HIV-1 RNA load.

Bezemer D, de Ronde A, Prins M, Porter K, Gifford R, Pillay D, Masquelier B, Fleury H, Dabis F, Back N, Jurriaans S, van der Hoek L; CASCADE collaboration. Bezemer D, et al. Among authors: pillay d. Antivir Ther. 2006;11(2):173-8. Antivir Ther. 2006. PMID: 16640098

6

Assessment of automated genotyping protocols as tools for surveillance of HIV-1 genetic diversity.

Gifford R, de Oliveira T, Rambaut A, Myers RE, Gale CV, Dunn D, Shafer R, Vandamme AM, Kellam P, Pillay D; UK Collaborative Group on HIV Drug Resistance. Gifford R, et al. Among authors: pillay d. AIDS. 2006 Jul 13;20(11):1521-9. doi: 10.1097/01.aids.0000237368.64488.ae. AIDS. 2006. PMID: 16847407

7

HIV resistance and the developing world.

Gupta RK, Pillay D. Gupta RK, et al. Among authors: pillay d. Int J Antimicrob Agents. 2007 May;29(5):510-7. doi: 10.1016/j.ijantimicag.2007.01.003. Epub 2007 Mar 7. Int J Antimicrob Agents. 2007. PMID: 17346940 Review.

8

Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1.

Gifford RJ, de Oliveira T, Rambaut A, Pybus OG, Dunn D, Vandamme AM, Kellam P, Pillay D; UK Collaborative Group on HIV Drug Resistance. Gifford RJ, et al. Among authors: pillay d. J Virol. 2007 Dec;81(23):13050-6. doi: 10.1128/JVI.00889-07. Epub 2007 Sep 26. J Virol. 2007. PMID: 17898057 Free PMC article.

9

Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials.

Gupta R, Hill A, Sawyer AW, Pillay D. Gupta R, et al. Among authors: pillay d. Clin Infect Dis. 2008 Sep 1;47(5):712-22. doi: 10.1086/590943. Clin Infect Dis. 2008. PMID: 18662137

10

The effect of antiretroviral treatment of different durations in primary HIV infection.

Pantazis N, Touloumi G, Vanhems P, Gill J, Bucher HC, Porter K; CASCADE Collaboration. Pantazis N, et al. AIDS. 2008 Nov 30;22(18):2441-50. doi: 10.1097/QAD.0b013e328319ea4e. AIDS. 2008. PMID: 19005267

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters